Manufacturing Facilities

VIRxSYS is the only company currently testing a lentiviral vector permitted for use by the FDA in Phase II clinical trials. Consequently, VIRxSYS is uniquely positioned to manufacture clinical-grade lentiviral vectors for therapies treating a wide range of life-threatening diseases. VIRxSYS is initially focused on using lentiviral vectors in cellular therapies for HIV/AIDS. VIRxSYS both… Continue reading Manufacturing Facilities

Published
Categorized as Technology

Intellectual Property

VIRxSYS has developed an extensive portfolio of intellectual property which is protected by a combination of patents, trade secrets, and trademark law. Below is a summary of the Company’s parent patents in the United States.  VIRxSYS also has many foreign counterparts in countries around the world. Patent/Ser No. Issue / Publication Date Title US 5,885,806… Continue reading Intellectual Property

Published
Categorized as Technology